Jiangsu Aidea Pharmaceutical Co., Ltd. (”Aidea Pharma”, 688488.SH) was established in 2009 and listed on the Shanghai Stock Exchange STAR Market in 2020. As a high-tech pharmaceutical company, Aidea Pharma focuses on the development of anti-HIV/AIDS product portfolio while leveraging its competitive advantages in the field of human urine-derived proteins production.
more >
Year of Establishment:
2009
Total Number of Staff:
500-1000
Main Competitive Advantages:
Brand Name,Experienced R&D Staff,Production Capacity,Reputation,Quality Service
Other Competitive Advantages:
Patents and Copyrights:
Business Type:
Manufacturer
R&D capacity:
Own Brand
Annual Turnover(USD):
500,000 to 99,999,999
Main Sales Markets:
Western Europe,Eastern Europe,Asia,Africa
Advantage Description: